Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
같은 분류의 다른 기사
Why our cyber stocks are dropping and our favorite memory play is rallying- Alibaba shares fall 3% as AI spending drives 75% drop in net income
- Walmart hikes full-year outlook, says it will use huge tariff refund to keep prices low
- Why we're giving off-price retailer TJX a pass for softness in its biggest division